These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 20305689)

  • 1. A deficiency in Mdm2 binding protein inhibits Myc-induced B-cell proliferation and lymphomagenesis.
    Odvody J; Vincent T; Arrate MP; Grieb B; Wang S; Garriga J; Lozano G; Iwakuma T; Haines DS; Eischen CM
    Oncogene; 2010 Jun; 29(22):3287-96. PubMed ID: 20305689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired ribosome biogenesis checkpoint activation induces p53-dependent MCL-1 degradation and MYC-driven lymphoma death.
    Domostegui A; Peddigari S; Mercer CA; Iannizzotto F; Rodriguez ML; Garcia-Cajide M; Amador V; Diepstraten ST; Kelly GL; Salazar R; Kozma SC; Kusnadi EP; Kang J; Gentilella A; Pearson RB; Thomas G; Pelletier J
    Blood; 2021 Jun; 137(24):3351-3364. PubMed ID: 33512431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 status dictates responses of B lymphomas to monotherapy with proteasome inhibitors.
    Yu D; Carroll M; Thomas-Tikhonenko A
    Blood; 2007 Jun; 109(11):4936-43. PubMed ID: 17284530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unexpected suppression of tumorigenesis by c-MYC via TFAP4-dependent restriction of stemness in B lymphocytes.
    Tonc E; Takeuchi Y; Chou C; Xia Y; Holmgren M; Fujii C; Raju S; Chang GS; Iwamoto M; Egawa T
    Blood; 2021 Dec; 138(24):2526-2538. PubMed ID: 34283887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of Vav-promoter-driven overexpression of BCLX and BFL1 on lymphocyte survival and B cell lymphomagenesis.
    Tuzlak S; Haschka MD; Mokina AM; Rülicke T; Cory S; Labi V; Villunger A
    FEBS J; 2018 Apr; 285(8):1403-1418. PubMed ID: 29498802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of gene expression during myc oncogene-induced lymphomagenesis in the bursa of Fabricius.
    Neiman PE; Ruddell A; Jasoni C; Loring G; Thomas SJ; Brandvold KA; Lee Rm ; Burnside J; Delrow J
    Proc Natl Acad Sci U S A; 2001 May; 98(11):6378-83. PubMed ID: 11353853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-B lymphomas in SL/Kh mice: a multifactorial disease model.
    Hiai H; Tsuruyama T; Yamada Y
    Cancer Sci; 2003 Oct; 94(10):847-50. PubMed ID: 14556656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell Cycle-Dependent TICRR/TRESLIN and MTBP Chromatin Binding Mechanisms and Patterns.
    Noble TD; Sansam CG; Wittig KA; Majchrzycka B; Sansam CL
    bioRxiv; 2024 Feb; ():. PubMed ID: 38370757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MTBP Promotes the Invasion and Metastasis of Hepatocellular Carcinoma by Enhancing the MDM2-Mediated Degradation of E-Cadherin.
    Lu S; Zhou W; Wei H; He L; Li L
    Dig Dis Sci; 2015 Dec; 60(12):3681-90. PubMed ID: 26280083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of an
    Ranjan A; Thoenen EA; Kaida A; Wood S; Van Dyke T; Iwakuma T
    Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons from Using Genetically Engineered Mouse Models of MYC-Induced Lymphoma.
    Winkler R; Piskor EM; Kosan C
    Cells; 2022 Dec; 12(1):. PubMed ID: 36611833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MTBP enhances the activation of transcription factor ETS-1 and promotes the proliferation of hepatocellular carcinoma cells.
    Wang H; Chu F; Zhijie L; Bi Q; Lixin L; Zhuang Y; Xiaofeng Z; Niu X; Zhang D; Xi H; Li BA
    Front Oncol; 2022; 12():985082. PubMed ID: 36106099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MTBP and MYC: A Dynamic Duo in Proliferation, Cancer, and Aging.
    Grieb BC; Eischen CM
    Biology (Basel); 2022 Jun; 11(6):. PubMed ID: 35741402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of MTBP as a Replication Origin Firing Factor.
    Zaffar E; Ferreira P; Sanchez-Pulido L; Boos D
    Biology (Basel); 2022 May; 11(6):. PubMed ID: 35741348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of DDK and Treslin-MTBP in coordinating replication licensing and pre-initiation complex formation.
    Volpi I; Gillespie PJ; Chadha GS; Blow JJ
    Open Biol; 2021 Oct; 11(10):210121. PubMed ID: 34699733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MTBP promoted the proliferation, migration and invasion of colon cancer cells by activating the expression of ZEB2.
    Shayimu P; Yusufu A; Rehemutula A; Redati D; Jiapaer R; Tuerdi R
    Anim Cells Syst (Seoul); 2021; 25(3):152-160. PubMed ID: 34262658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MTBP phosphorylation controls DNA replication origin firing.
    Ferreira P; Höfer V; Kronshage N; Marko A; Reusswig KU; Tetik B; Dießel C; Köhler K; Tschernoster N; Altmüller J; Schulze N; Pfander B; Boos D
    Sci Rep; 2021 Feb; 11(1):4242. PubMed ID: 33608586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse Models of
    Ferrad M; Ghazzaui N; Issaoui H; Cook-Moreau J; Denizot Y
    Front Immunol; 2020; 11():1564. PubMed ID: 32793219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MTBP regulates cell survival and therapeutic sensitivity in TP53 wildtype glioblastomas.
    Song Y; Zhang L; Jiang Y; Hu T; Zhang D; Qiao Q; Wang R; Wang M; Han S
    Theranostics; 2019; 9(20):6019-6030. PubMed ID: 31534534
    [No Abstract]   [Full Text] [Related]  

  • 20. MTBP promotes migration and invasion by regulation of ZEB2-mediated epithelial-mesenchymal transition in lung cancer cells.
    Pan B; Han H; Wu L; Xiong Y; Zhang J; Dong B; Yang Y; Chen J
    Onco Targets Ther; 2018; 11():6741-6756. PubMed ID: 30349307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.